# Isabella Bank Corp: overview ISBA · Nasdaq · CIK 842517 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/isba.md) · [Financials](/companies/isba/financials.md) · [Filings](/companies/isba/filings.md) · [Insiders](/companies/isba/insiders.md) Latest reported revenue: [$1.4m](/filings/0000842517-19-000166.md) for Q3 FY2019, three months to 2019-09-30, from the 10-Q filed Nov 6, 2019 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000842517-19-000166). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.44](/filings/0000842517-25-000210.md) | not reported | [0.53](/filings/0000842517-26-000099.md) | [0.68](/filings/0000842517-26-000180.md) | [0.71](/filings/0000842517-25-000210.md) | not reported | [0.68](/filings/0000842517-26-000099.md) | [0.69](/filings/0000842517-26-000180.md) | | Free cash flow | $m | [3.2 d](/filings/0000842517-25-000210.md) | [6.6 d](/filings/0000842517-26-000069.md) | [3.7](/filings/0000842517-26-000099.md) | [7.2 d](/filings/0000842517-26-000180.md) | [1.8 d](/filings/0000842517-25-000210.md) | [10.6 d](/filings/0000842517-26-000069.md) | [3.2](/filings/0000842517-26-000099.md) | [7.3 d](/filings/0000842517-26-000180.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [2.45](/filings/0000842517-24-000048.md) | [2.91](/filings/0000842517-25-000053.md) | [2.40](/filings/0000842517-26-000069.md) | [1.86](/filings/0000842517-26-000069.md) | [2.56](/filings/0000842517-26-000069.md) | | Free cash flow | $m | [23.9](/filings/0000842517-24-000048.md) | [23.7](/filings/0000842517-25-000053.md) | [20.1](/filings/0000842517-26-000069.md) | [17.5](/filings/0000842517-26-000069.md) | [23.3](/filings/0000842517-26-000069.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/isba/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $18.5m | 467,431 | | Added +367,230 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $11.8m | 299,599 | | Added +25,551 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $7.0m | 176,251 | | Added +95,849 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $3.4m | 86,581 | | Added +64,529 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $2.1m | 53,471 | | Added +38,731 | | [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.8m | 46,742 | | New +46,742 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $1.8m | 46,482 | | Added +5,728 | | [HARBOUR INVESTMENTS, INC.](/funds/810121.md) | 2026-06-30 | $1.3m | 32,988 | | Added +5,967 | | [VICTORY CAPITAL MANAGEMENT INC](/funds/1040188.md) | 2026-06-30 | $1.2m | 31,000 | | New +31,000 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $1.1m | 27,462 | | Added +6,637 | ## Recent filings [All 1,711 filings](/companies/isba/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-06 | 16:53 ET | [8-K](/filings/0000842517-26-000227.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000842517-26-000227 | | 2026-09-28 | 16:30 ET | [8-K](/filings/0000842517-26-000224.md) | 8.01 Other events | 0000842517-26-000224 | | 2026-09-21 | 16:30 ET | [8-K](/filings/0000842517-26-000222.md) | 8.01 Other events | 0000842517-26-000222 | | 2026-08-27 | 16:32 ET | [8-K](/filings/0000842517-26-000190.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000842517-26-000190 | | 2026-08-14 | 11:00 ET | [8-K](/filings/0000842517-26-000184.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000842517-26-000184 | | 2026-08-10 | 11:01 ET | [10-Q](/filings/0000842517-26-000180.md) | Quarterly report, period 2026-06-30 | 0000842517-26-000180 | | 2026-07-23 | 16:19 ET | [8-K](/filings/0000842517-26-000176.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000842517-26-000176 | | 2026-06-16 | 09:16 ET | [8-K](/filings/0000842517-26-000163.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000842517-26-000163 | | 2026-06-15 | 17:17 ET | [8-K](/filings/0000842517-26-000158.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000842517-26-000158 | | 2026-06-12 | 09:17 ET | [8-K](/filings/0000842517-26-000138.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000842517-26-000138 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000842517-26-000069.md), filed Mar 13, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 842517 - Tickers: ISBA - Exchange: Nasdaq - SIC code: 6022 State Commercial Banks - State of incorporation: MI - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 08:35 ET. No prices; not investment advice.